If you have been diagnosed with a Xeljanz side effect, you may have a case for financial compensation. If you have questions about the legal process, contact the Showard Law Firm for a free case evaluation. You can also learn about the statute of limitations for Xeljanz lawsuit.
Xeljanz side effects
Xeljanz has caused a series of lawsuits, and Pfizer is likely to face many of them. The drug is a cancer treatment that manipulates enzymes in the body that control the growth and spread of new cells. While Pfizer initially denied any connection between the drug and cancer, it eventually agreed to switch patients to lower doses to reduce the risk of cancer. Unfortunately, this has caused some patients to suffer life-threatening side effects, and Pfizer is trying to protect its business by denying responsibility. That’s why it’s important to work with a lawyer who has experience with this type of lawsuit.
Xeljanz lawsuit statute of limitations
In most states, the statute of limitations on bringing a lawsuit against a drug company is two years. However, in some cases, the statute of limitations may be extended depending on the circumstances. If your case is filed after this time period has passed, the court will dismiss your lawsuit. Therefore, you need to contact a qualified attorney to discuss your legal options.
Xeljanz safety studies
After being approved for use in the treatment of rheumatoid arthritis, Pfizer’s Xeljanz drug has undergone a series of safety studies. These studies involved 4,362 patients who were randomly assigned to either take five mg or ten mg of the drug each day. The results of the study showed that patients taking the drug had higher rates of major adverse cardiovascular events and adjudicated malignancies compared to those taking the placebo.
Xeljanz cancer risk
If you’re considering taking Xeljanz to treat your rheumatoid arthritis, you should be aware of the potential cancer risk associated with this drug. This medicine has already been linked to other problems, including heart problems, blood clots, and Epstein-Barr virus reactivation.
Xeljanz heart risk
The pharmaceutical company Pfizer is facing serious liabilities after a recent study showed that Xeljanz causes a significantly increased risk of blood clots and cardiovascular problems. Although the warnings about the potential for blood clots were relatively recent, the company failed to warn consumers of the serious risk associated with the drug. As a result, the company will likely be named in hundreds of lawsuits related to Xeljanz.
Xeljanz pulmonary embolism risk
Xeljanz is a prescription drug that can cause dangerous blood clots in the lungs. This condition is known as pulmonary embolism and can have life-threatening consequences. The manufacturer of Xeljanz has been ordered by the FDA to update the warning label to inform patients of this risk. Despite this requirement, a number of Xeljanz lawsuits have been filed in recent months, alleging that the drug manufacturer failed to warn consumers of the risk of pulmonary embolism.
Alternatives to Xeljanz
The FDA has approved the cancer drug Xeljanz, but it has also caused some serious side effects. The drug has received “black box” warnings, which are the most serious warnings the FDA can impose. It has already been linked to serious infections and cancer. However, post-marketing studies have now revealed another life-threatening side effect. This can lead to lawsuits claiming that the drug failed to adequately warn patients of serious risks.
